Stryker (FRA:SYK) Common Stock : €35 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Stryker Common Stock?

Stryker's quarterly common stock declined from Sep. 2023 (€36 Mil) to Dec. 2023 (€35 Mil) but then increased from Dec. 2023 (€35 Mil) to Mar. 2024 (€35 Mil).

Stryker's annual common stock increased from Dec. 2021 (€34 Mil) to Dec. 2022 (€36 Mil) but then declined from Dec. 2022 (€36 Mil) to Dec. 2023 (€35 Mil).

Stryker Common Stock Historical Data

The historical data trend for Stryker's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Common Stock Chart

Stryker Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

33.30

31.24

33.63

35.87

34.85

Stryker Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															35.49	35.07	35.61	34.85	34.96

Stryker Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Stryker (FRA:SYK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (FRA:SYK) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

SYK:USA SYK:Mexico 1SYK:Italy S1YK34:Brazil SYK:Austria

Address

2825 Airview Boulevard, Kalamazoo, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.